COPD & Emphysema Support Group
COPD is a progressive disease characterized by airflow obstruction or limitation. Emphysema is characterized by loss of elasticity of the lung tissue, destruction of structures supporting the alveoli and of capillaries feeding the alveoli. Both have symptoms that include shortness of breath, among other respiratory troubles. If you are a COPD or Emphysema sufferer, join...
Interesting article.
SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN - News) announced today its majority owned subsidiary, Entest BioMedical unit (OTCBB: ENTB - News), has filed a patent application for the use of adipose derived stem cells in the treatment of Chronic Obstructive Pulmonary Disease (COPD). BMSN is excited with the progress achieved by Entest BioMedical, Inc. (OTCBB: ENTB - News) in identifying diseases it believes will be treatable through Stem Cell Therapy.
Article: http://tinyurl.com/l5fgdl
SAN DIEGO--(BUSINESS WIRE)--Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN - News) announced today its majority owned subsidiary, Entest BioMedical unit (OTCBB: ENTB - News), has filed a patent application for the use of adipose derived stem cells in the treatment of Chronic Obstructive Pulmonary Disease (COPD). BMSN is excited with the progress achieved by Entest BioMedical, Inc. (OTCBB: ENTB - News) in identifying diseases it believes will be treatable through Stem Cell Therapy.
Article: http://tinyurl.com/l5fgdl
Hugs, Laurie
therapy. Just wonder how long after they get the patent before they can actually use it on copd patients. I hope this is what alot of us
have been waiting for.
Nellie
and I think our greatest hope...
Breath Easy everyone,
and Have a nice day,
Holy
Thanks for the info Arlene.